Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-21T14:36:44.915Z Has data issue: false hasContentIssue false

Influence of BCG dose and age of inoculated mice on immunoprotection against tuberculosis and expression of IFN-γ/IL-4

Published online by Cambridge University Press:  30 October 2009

Guo Hui-Jun
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
Li Bao-Quan
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
Chai Jia-Qian
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
Chang Wei-Shan
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
Wang Chun-Yang
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
Li Hong-Mei*
Affiliation:
College of Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, China
*
*Corresponding author. E-mail: lihm@sdau.edu.cn

Abstract

BalB/C neonate mice and adult BalB/C mice were vaccinated using BCG (Bacille Calmette–Guerin). The pathogenic growth characteristics of BCG in in vitro culture on spleen cells (SPC) were observed and changes in induced expression of IFN (interferon)-γ and IL (interleukin)-4 in SPC were detected using the ELISPOT assay. The results showed that a low dose of BCG (2×103 cfu) exerted 100% immunoprotection on 7-day-old neonate mice and a high dose of BCG (4×104 cfu) exerted 75% immunoprotection. A low dose of BCG (2×103 cfu) exerted 67% immunoprotection on 35-day-old mice. It is also shown that Th1-type cell immunity dominated by IFN-γ was enhanced significantly in the neonate mice injected with a low dose of BCG (2×103 cfu), and Th2-type cell immunity dominated by IL-4 was depressed at the same time. IFN-γ and IL-4 induced by a high dosage of BCG (4×104 cfu) in neonate mice were both increased. IFN-γ and IL-4 induced by a low dose of BCG (2×103 cfu) in 35-day-old mice were also increased. The results indicate that there exists a marked correlation between immunoprotection by BCG in mice and both the immunizing dose and age of the immune animals, which might be relevant to the changes induced by BCG on Th1- and Th2-type cell immunity.

Type
Research Papers
Copyright
Copyright © China Agricultural University 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brandt, L, Cunha, JF, Olsen, AW, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infection and Immunity 70: 672678.CrossRefGoogle ScholarPubMed
Buddle, BM, Wards, BJ, Aldwell, FE, Collins, DM and de Lisle, GW (2002) Influence of sensitization to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20(7–8): 11261133.CrossRefGoogle ScholarPubMed
Buddle, BM, Wedlock, DN, Parlane, NA, Corner, LA, De Lisle, MA and Skinner, MA (2003) Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infection and Immunity 71: 64116419.CrossRefGoogle ScholarPubMed
Buddle, BM, Wedlock, DN, Denis, M and Skinner, MA (2005) Identification of immune response correlates for protection against bovine tuberculosis. Veterinary Immunology and Immunopathology 108(1–2): 4551.CrossRefGoogle ScholarPubMed
Buddle, BM, Wedlock, DN and Denis, M (2006) Progress in the development of tuberculosis vaccines for cattle and wildlife. Veterinary Microbiology 112(2–4): 191200.CrossRefGoogle ScholarPubMed
Denis, M, Wedlock, DN and Buddle, BM (2005) IFN-gamma enhances bovine macrophage responsiveness to Myco-bacterium bovis: impact on bacterial replication, cytokine release and macrophage apoptosis. Immunology and Cell Biology 83(6): 643650.CrossRefGoogle Scholar
Denis, M, Keen, DL, Parlane, NA, Storset, AK and Buddle, BM (2007) Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages. Tuberculosis (Edinb) 87(1): 5362.CrossRefGoogle ScholarPubMed
Doherty, TM, Demissie, A, Menzies, D, Andersen, P, Rook, G and Zumla, A; VACSEL Study Group (2005) Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. Journal of Immunological Methods 298: 129141.CrossRefGoogle ScholarPubMed
Fine, PEM (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 13391345.CrossRefGoogle ScholarPubMed
Fine, PEM and Vynnycky, E (1998) The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines. Vaccine 20(16): 19231928.CrossRefGoogle Scholar
Hope, JC, Thom, ML, Villarreal-Ramos, B, Vordermeier, HM, Hewinson, RG and Howard, CJ (2005) Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clinical and Experimental Immunology 139(1): 4856.CrossRefGoogle ScholarPubMed
Kaufmann, SH (2006) Envisioning future strategies for vaccination against tuberculosis. Nature Reviews: Immunology 6(9): 699704.Google ScholarPubMed
Kuang, TJ, Song, P, Wang, LP, Tan, ZL, Wang, ZY and Xue, JL (1995) Simplified cultural mediums for the growth of BCG and the calculation of tuberculosis forms. Journal of Microbiology 35: 298302.Google Scholar
Lyashchenko, K, Whelan, AO, Greenwald, R, et al. (2004) Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infection and Immunity 72: 24622467.CrossRefGoogle ScholarPubMed
Marchant, A, Goetghebuer, T, Ota, MO, et al. (1999) Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette–Guerin vaccination. Journal of Immunology 163(4): 22492255.CrossRefGoogle ScholarPubMed
Power, CA, Grand, CL, Ismail, N, Peters, NC, Yurkowski, DP and Bretscher, PA (1999) A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFN gamma-producing T cells. Journal of Immunology Methods 227(1–2): 99107.CrossRefGoogle Scholar
Smith, GC, Bennett, R, Wilkinson, D and Cooke, R (2007) Bovine tuberculosis–another view from down under. The Veterinary Journal 173: 233234.Google Scholar
Suazo, FM, Escalera, AM and Torres, RM (2003) A review of M. bovis BCG protection against TB in cattle and other animal species. Preventive Veterinary Medicine 58(1–2): 113.CrossRefGoogle Scholar
Vekemans, J, Amedei, A, Ota, MO, et al. (2001) Neonatal bacillus Calmette–Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. European Journal of Immunology 31(5): 15311535.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Vordermeier, M and Hewinson, RG (2006) Development of cattle TB vaccines in the UK. Veterinary Immunology and Immunopathology 112(1–2): 3848.CrossRefGoogle ScholarPubMed
Vordermeier, HM, Chambers, MA, Buddle, BM, Pollock, JM and Hewinson, RG (2006) Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. The Veterinary Journal 171: 229244.CrossRefGoogle ScholarPubMed
Wang, YX, Yu, SK and Zhai, JJ (2006) Current status and diagnosis research on bovine tuberculosis. Progress in Veterinary Medicine 27(6): 3841 (in Chinese).Google Scholar
WHO (2005) WHO Report, Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: World Health Organization.Google Scholar
Zhang, SQ, Zhang, P, Liu, SS and Sun, DW (1997) Experiment on inoculation with BCG to protect against tuberculosis in cattle. Acta Microbiologica Sinica 17(2): 3940 (in Chinese).Google Scholar
Zhu, JG and Hua, XG (2005) Current status on bovine tuberculosis. Chinese Journal of Preventive Veterinary Medicine 27(5): 423426 (in Chinese with English abstract).Google Scholar